Buchwald, D, Wener, M H, Komaroff, A L · Arthritis and rheumatism · 1991 · DOI
This study looked at whether people with ME/CFS who have neurological symptoms (like problems with thinking or nerve function) have unusual antibodies in their blood that attack nerve cells. Researchers tested blood samples from ME/CFS patients and compared antibody levels between those with and without neurological problems. The goal was to understand whether immune system misdirection might be causing some of the neurological symptoms patients experience.
This research was pioneering in investigating whether immune-mediated neuronal damage contributes to ME/CFS symptoms. Understanding potential autoimmune mechanisms could eventually lead to better diagnostic tools and targeted treatments for patients experiencing neurological complications.
This study does not prove that anti-neuronal antibodies cause ME/CFS or neurological symptoms—it only shows an association. The study cannot establish causation, and the presence of antibodies does not necessarily mean they are pathogenic or responsible for patient symptoms. Findings from 1991 would require replication with modern serological techniques and larger cohorts.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.